"We are working with a biotech company, Calypte, which has designed a urine test for the HIV antibody"
- Luc Montagnier
About this Quote
This quote by Luc Montagnier speaks to the importance of biotechnology in the battle versus HIV. By dealing with Calypte, a biotech business, Montagnier is suggesting that the development of a urine test for the HIV antibody is a significant step forward in the battle versus the infection. This test will permit a more accurate and efficient method to find the presence of the infection in an individual's body. The advancement of this test is a significant breakthrough in the fight against HIV, as it will allow for earlier detection and treatment of the infection. This test will also help to lower the preconception related to HIV, as it will enable more precise and timely diagnosis. Montagnier's quote speaks to the significance of biotechnology in the fight versus HIV, and the potential for this new urine test to make a significant effect in the fight against the infection.
"Our DNA is as a consumer company - for that individual customer who's voting thumbs up or thumbs down. That's who we think about. And we think that our job is to take responsibility for the complete user experience. And if it's not up to par, it's our fault, plain and simply"
"Going to work for a large company is like getting on a train. Are you going sixty miles an hour or is the train going sixty miles an hour and you're just sitting still?"
"Only as long as a company can produce a desired, worthwhile, and needed product or service, and can command the public, will it receive the public dollar and succeed"
"Nobody's irreplaceable, including me. I think for too long we've had a cult of personality in this company and in this industry, and frankly, I'd like to see that diminish"
"Shareholder activism is not a privilege - it is a right and a responsibility. When we invest in a company, we own part of that company and we are partly responsible for how that company progresses. If we believe there is something going wrong with the company, then we, as shareholders, must become active and vocal"
